X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8839) 8839
Book Review (1403) 1403
Publication (1126) 1126
Book Chapter (90) 90
Dissertation (44) 44
Conference Proceeding (38) 38
Book / eBook (16) 16
Web Resource (9) 9
Magazine Article (5) 5
Journal / eJournal (3) 3
Data Set (2) 2
Paper (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6327) 6327
humans (5768) 5768
female (4889) 4889
human papillomavirus (4180) 4180
hpv (3690) 3690
cervical cancer (3573) 3573
adult (2933) 2933
cancer (2581) 2581
papillomavirus infections (2516) 2516
adolescent (2285) 2285
vaccination (2267) 2267
women (2153) 2153
papillomavirus infections - prevention & control (2148) 2148
vaccines (2147) 2147
middle aged (1979) 1979
prevalence (1771) 1771
oncology (1723) 1723
male (1702) 1702
young adult (1701) 1701
papillomavirus infections - virology (1604) 1604
immunization (1538) 1538
papillomavirus infections - epidemiology (1521) 1521
infection (1509) 1509
immunology (1503) 1503
hpv vaccine (1430) 1430
uterine cervical neoplasms - virology (1429) 1429
uterine cervical neoplasms - prevention & control (1366) 1366
health aspects (1324) 1324
prevention (1307) 1307
cervical-cancer (1285) 1285
papillomavirus vaccines - administration & dosage (1218) 1218
risk factors (1194) 1194
public, environmental & occupational health (1147) 1147
papillomaviruses (1129) 1129
united-states (1059) 1059
research (1022) 1022
aged (1015) 1015
hpv vaccination (1014) 1014
infectious diseases (1000) 1000
papillomaviridae - genetics (1000) 1000
analysis (981) 981
papillomaviridae - isolation & purification (915) 915
young-women (899) 899
vaccine (886) 886
child (884) 884
epidemiology (869) 869
medicine, research & experimental (855) 855
risk (849) 849
papillomavirus infections - complications (835) 835
article (811) 811
health knowledge, attitudes, practice (790) 790
diagnosis (767) 767
genotype (751) 751
virus diseases (744) 744
papillomavirus infections - diagnosis (739) 739
infections (735) 735
hpv infection (728) 728
obstetrics & gynecology (727) 727
papillomavirus vaccines - immunology (706) 706
dna (686) 686
cervical intraepithelial neoplasia (682) 682
uterine cervical neoplasms - epidemiology (676) 676
public health (675) 675
intraepithelial neoplasia (651) 651
particle vaccine (642) 642
virology (627) 627
knowledge (626) 626
human-papillomavirus (624) 624
womens health (618) 618
papillomavirus vaccines (616) 616
attitudes (608) 608
uterine cervical neoplasms - diagnosis (586) 586
cross-sectional studies (584) 584
papillomavirus vaccines - therapeutic use (570) 570
papillomaviridae - classification (545) 545
cervical intraepithelial neoplasia - virology (540) 540
surveys and questionnaires (539) 539
lesions (533) 533
adolescents (530) 530
female genital diseases and pregnancy complications (530) 530
allergy and immunology (521) 521
natural-history (515) 515
cytology (514) 514
cervix (513) 513
medical screening (494) 494
papillomavirus infections - immunology (487) 487
research article (472) 472
efficacy (470) 470
human-papillomavirus infection (460) 460
medical research (453) 453
microbiology (453) 453
studies (452) 452
sexually transmitted diseases (446) 446
acceptability (444) 444
care and treatment (440) 440
medicine, general & internal (440) 440
screening (435) 435
vaginal smears (432) 432
incidence (425) 425
abridged index medicus (424) 424
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8578) 8578
German (105) 105
French (103) 103
Spanish (82) 82
Japanese (31) 31
Korean (28) 28
Polish (26) 26
Swedish (18) 18
Portuguese (14) 14
Chinese (12) 12
Croatian (9) 9
Czech (8) 8
Russian (5) 5
Turkish (5) 5
Hungarian (3) 3
Italian (3) 3
Serbian (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 07/2015, Volume 11, Issue 7, pp. 1689 - 1702
This observer-blind study (clinicaltrials.gov NCT01462357) compared the immunogenicity and safety of 2 doses of the HPV-16/18 AS04-adjuvanted vaccine... 
y, year(s) | AAHS, aluminum hydroxyphosphate sulfate | CI, confidence interval | PBMC, peripheral blood mononuclear cells | ELISA, enzyme-linked immunosorbent assay | M, month(s) | ELISPOT, enzyme-linked immunosorbent spot assay | human papillomavirus (HPV) vaccines | HPV-6/11/16/18(3D), 3-dose schedule of the HPV-6/11/16/18 vaccine | safety | ANOVA, analysis of variance | female adolescents | 50 | PBNA, pseudovirion-based neutralisation assay | GMT, geometric mean antibody titer | ED | 2D, 2-dose | AS04, Adjuvant System containing 50 µg 3-O-desacyl-4 ′-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 µg Al | CMI, cell-mediated immunity | 3D, 3-dose | ) | SAE, serious adverse event | immunogenicity | HPV, human papillomavirus | IgG, immunoglobulin G | TVC, total vaccinated cohort | 3 | ATP-I, according-to-protocol immunogenicity cohort | effective dose producing 50% response | HPV-16/18(2D), 2-dose schedule of the HPV-16/18 vaccine | IFNγ, interferon | VLP, virus-like particle | administration schedule | GMR, geometric mean titer ratio | EU, ELISA unit | HPV-6/11/16/18(2D), 2-dose schedule of the HPV-6/11/16/18 vaccine | pIMD, potential immune-mediated disease | Administration schedule | Safety | Immunogenicity | Human papillomavirus (HPV) vaccines | Female adolescents | PBNA | TVC | enzyme-linked immunosorbent spot assay | pIMD | CLINICAL-TRIAL | potential immune-mediated disease | OF-STUDY ANALYSIS | ELISA unit | IMMUNOLOGY | NEUTRALIZATION ASSAY | 18(3D) | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | geometric mean antibody titer | BLIND PATRICIA TRIAL | CMI | 2-dose | pseudovirion-based neutralisation assay | AS04 | CERVICAL-CANCER | GMR | PBMC | GMT | MEMORY B-CELLS | according-to-protocol immunogenicity cohort | AAHS | PARTICLE VACCINE | SAE | human papillomavirus | HPV VACCINE | ELISA | ATP-I | month(s) | virus-like particle | 3-dose | geometric mean titer ratio | IgG | 2-dose schedule of the HPV-16 | HPV | 18 vaccine | IFN | 18(2D) | CD154 EXPRESSION | analysis of variance | ANOVA | serious adverse event | total vaccinated cohort | year(s) | ED50 | VLP | YOUNG-WOMEN | Adjuvant System containing 50 mu g 3-O-desacyl-4-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 mu g Al3+) | peripheral blood mononuclear cells | aluminum hydroxyphosphate sulfate | immunoglobulin G | 3-dose schedule of the HPV-6 | HPV-16 | HPV-6 | 2-dose schedule of the HPV-6 | interferon | ELISPOT | enzyme-linked immunosorbent assay | confidence interval | cell-mediated immunity | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - adverse effects | Adjuvants, Immunologic - administration & dosage | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - immunology | Vaccine Potency | Humans | Alphapapillomavirus - immunology | Antibodies, Viral - blood | Immunity, Humoral | Time Factors | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Vaccines - adverse effects | Female | Immunization Schedule | Papillomavirus Vaccines - immunology | Child | Immunity, Cellular | Papillomavirus Vaccines - administration & dosage | Antibodies, Neutralizing - blood | Index Medicus | Medical and Health Sciences | Basic Medicine | Medicinsk bioteknologi | Medical Biotechnology | Medicin och hälsovetenskap | Immunologi inom det medicinska området | Immunology in the medical area | Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) | Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Journal Article
Side Effects of Drugs Annual, ISSN 0378-6080, 2014, Volume 36, pp. 465 - 482
Journal Article
01/2013, 6, ISBN 9781455700905, 1551
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world."... 
Vaccines
eBook
Human Vaccines, ISSN 1554-8600, 12/2011, Volume 7, Issue 12, pp. 1343 - 1358
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, pp. e0160099 - e0160099
The objective of this study was to determine the prevalence and some predictors for vaccine and non-vaccine types of HPV infections among bivalent HPV... 
HUMAN-PAPILLOMAVIRUS TYPES | HIV | EFFICACY | HIGH COVERAGE | MULTIDISCIPLINARY SCIENCES | INVASIVE CERVICAL-CANCER | VISUAL INSPECTION | PREVALENCE | ACETIC-ACID | KAMPALA | HPV TYPES | Mass Vaccination | Human papillomavirus 18 - immunology | Coinfection | Prevalence | HIV Infections - epidemiology | Humans | Immunization Programs - organization & administration | Uganda - epidemiology | Human papillomavirus 16 - drug effects | Human papillomavirus 16 - immunology | Young Adult | HIV Infections - microbiology | Papillomavirus Infections - immunology | Female | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Genotype | Syphilis - epidemiology | Syphilis - microbiology | Pilot Projects | Human papillomavirus 18 - drug effects | Papillomavirus Infections - prevention & control | Adolescent | Human papillomavirus 16 - genetics | Care and treatment | Vaccination | Causes of | Genetic aspects | Research | Comparative analysis | Health aspects | Papillomavirus infections | Immunization | Urban areas | CD8 antigen | Health risks | Infections | Vaccines | Risk analysis | Girls | Risk factors | CD4 antigen | Sexually transmitted diseases | Human papillomavirus | Genotyping | Body mass | Womens health | Syphilis | Strains (organisms) | Sexual partners | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Eurosurveillance, ISSN 1025-496X, 04/2018, Volume 23, Issue 17, pp. 30 - 39
Background: Vaccine hesitancy (VH) is prominent in France. Objectives: This study aimed to estimate the prevalence and socio-demographic correlates of VH in... 
INFECTIOUS DISEASES | ADOLESCENTS | COVERAGE | REASONS | HPV VACCINATION | PARENTS | CHILDHOOD | STRATEGIES | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 06/2015, Volume 34, Issue 6, pp. 627 - 634
Journal Article
Infection, Genetics and Evolution, ISSN 1567-1348, 10/2017, Volume 54, pp. 402 - 416
Human papillomavirus (HPV)-caused cervical cancer is the fourth common female cancer globally. Despite availability of three effective vaccines in market,... 
Human papillomavirus (HPV) vaccine | Vaccine design | Minor capsid protein (L2) | Cervical cancer (CxCa) | Immunoinformatics | IMMUNE-RESPONSE | INFECTIOUS DISEASES | IN-SILICO | PROTEIN-STRUCTURE | ESCHERICHIA-COLI | SUBUNIT VACCINES | HUMAN-PAPILLOMAVIRUS VACCINES | TOLL-LIKE RECEPTORS | CROSS-NEUTRALIZING EPITOPE | SELF-ADJUVANTING ANTIGEN | FEMALE REPRODUCTIVE-TRACT | Papillomavirus Vaccines - genetics | Vaccines, Subunit - genetics | Humans | Epitopes, T-Lymphocyte - genetics | Epitopes, B-Lymphocyte - immunology | Papillomaviridae - genetics | Papillomaviridae - immunology | Epitopes, B-Lymphocyte - genetics | Flagellin - genetics | Malaria Vaccines - immunology | Capsid Proteins - immunology | Adjuvants, Immunologic - genetics | Oncogene Proteins, Viral - genetics | Epitopes, T-Lymphocyte - immunology | Computational Biology - methods | Flagellin - immunology | Vaccines, Subunit - chemistry | Vaccines, Subunit - immunology | Molecular Dynamics Simulation | Animals | Papillomavirus Vaccines - chemistry | Papillomavirus Infections - prevention & control | Papillomavirus Vaccines - immunology | Molecular Docking Simulation | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Malaria Vaccines - genetics | Prevention | Peptides | Viral proteins | Analysis | Molecular dynamics | Vaccines | T cells | Health aspects | Papillomavirus infections | Cervical cancer | Antigenic determinants | Cancer | Index Medicus
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 12/2018, Volume 84, Issue 12, pp. 2928 - 2932
Aims Methods Human papillomavirus (HPV) vaccines prevent infection with oncogenic virus types. We analysed reports to the US Vaccine Adverse Event Reporting... 
vaccine safety | immunization | bivalent human papillomavirus vaccine (2vHPV) | vaccine adverse event reporting system (VAERS) | vaccination | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | Papillomaviruses | Safety and security measures | Analysis | Vaccination | Vaccines | Data mining | Health aspects | Papillomavirus infections
Journal Article